Oligonucleotides are short nucleic acid polymers used in various molecular biology techniques such as sequencing, cloning, in situ hybridization and others. Oligonucleotide synthesis finds applications in development of diagnostic tools, therapeutic development and other research activities. The growing incidences of chronic diseases and focus on precision medicine is driving huge investments in R&D which in turn is augmenting the demand for oligonucleotide synthesis.
The global Oligonucleotide Synthesis Market is estimated to be valued at US$ 4565 Bn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Rising R&D investments is one of the key trends fueling growth of the oligonucleotide synthesis market. Biopharma and biotech companies are investing significantly in development of novel therapeutics such as oligonucleotide drugs which require oligonucleotides at different stages of development. Furthermore, growth in clinical trials is also promoting oligonucleotide synthesis. With increasing incidence of chronic diseases, focus on precision medicine and development of personalized therapeutics is growing exponentially. This is encouraging research related to biomarker identification, target identification and validation, which involve extensive use of oligonucleotides thereby driving the market growth over the forecast period.
Segment Analysis
The global oligonucleotide synthesis market is dominated by the synthesis or reagents and equipment segment. This segment contributes over 60% revenue share owing to the wide applications of oligonucleotides that drives the demand for various reagents and equipment required for oligonucleotide synthesis. The reagents sub-segment accounts for the largest share as different reagents are required for various oligonucleotide synthesis chemistries. Within equipment, DNA synthesizers sub-segment dominates as it is the core equipment required for large-scale oligonucleotide synthesis.
Key Takeaways
The global oligonucleotide synthesis market is expected to witness high growth over the forecast period of 2024 to 2031.
Regional analysis shows that North America is currently the largest as well as the fastest growing regional market. This is attributed to the strong foothold of key market players and robust research environment in the region that drives R&D investment in oligonucleotide therapeutics.
Key players operating in the oligonucleotide synthesis market are Forte Research Systems (India), ICON plc (Ireland), Merge healthcare incorporated (U.S.), Bio-Optronics (U.S.), DSG INC (U.S.), ArisGlobal (India), ERT Clinical Bioclinica (U.S.), Oracle Corporation (U.S.), Medidata Solutions (U.S.), DATATRAK International, Inc. (U.S.), and MedNet Solutions, Inc., (U.S.) among others. The market is highly consolidated with top three players accounting for over 55% of the global market share. Market leaders are focusing on new product launches, geographical expansion and acquisitions to strengthen their market position.
For more Insights, Read –
This report focuses on top manufacturers in global market, with Sales, price, revenue and market share for each manufacturer, coveringGenescriptGeneArt (Thermofischer)IDTDNA 2.0 (ATUM)OriGeneBBIGenewizEurofins GenomicsGene OracleSBS GenetechBio BasicDownload FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-oligonucleotide-synthesis-2018-994On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split intoPrimersProbesIntermediate-scale Synthesis OligosLarge-scale Synthesis OligosLinkers and AdaptorsBy Application, the market can be split intoChinaUSAEuropeJapanKoreaIndiaSoutheast AsiaSouth AmericaBy Regions, this report covers (we can add the regions/countries as you want)If you have any special requirements, please let us know and we will offer you the report as you want.Get the Complete Report & TOC @ https://www.grandresearchstore.com/energy-and-natural-resources/global-oligonucleotide-synthesis-2018-994Table of content1 Report Overview1.1 Definition and Specification1.2 Report Overview1.2.1 Manufacturers Overview1.2.2 Regions Overview1.2.3 Type Overview1.2.4 Application Overview1.3 Industrial Chain1.3.1 Oligonucleotide Synthesis Overall Industrial Chain1.3.2 Upstream1.3.3 Downstream1.4 Industry Situation1.4.1 Industrial Policy1.4.2 Product Preference1.4.3 Economic/Political Environment1.5 SWOT Analysis2 Market Analysis by Types2.1 Overall Market Performance(Volume)2.1.1 Primers Market Performance (Volume)2.1.2 Probes Market Performance (Volume)2.1.3 Intermediate-scale Synthesis Oligos Market Performance (Volume)2.1.4 Large-scale Synthesis Oligos Market Performance (Volume)2.1.5 Linkers and Adaptors Market Performance (Volume)2.2 Overall Market Performance(Value)2.1.1 Primers Market Performance (Value)2.1.2 Probes Market Performance (Value)2.1.3 Intermediate-scale Synthesis Oligos Market Performance (Value)2.1.4 Large-scale Synthesis Oligos Market Performance (Value)2.1.5 Linkers and Adaptors Market Performance (Value)3 Product Application Market3.1 Overall Market Performance (Volume)CONTACT US:276 5th Avenue, New York , NY 10001,United StatesInternational: (+1) 646 781 7170 / +91 8087042414Email: [email protected] Us On linkedin :- https://www.linkedin.com/company/grand-research-store/
